Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mumtaz Saifi"'
Autor:
Moushumi Suryavanshi, Anurag Mehta, Manoj Kumar Panigrahi, Jiten Jaipuria, Mumtaz Saifi, Kavita Jain, Dushyant Kumar, Haristuti Verma, Sanjeev Kumar Sharma, Ullas Batra, Kumardeep Dutta, Vineet Talwar, Dinesh Chandra Doval
Publikováno v:
Lung India, Vol 35, Iss 5, Pp 384-389 (2018)
Background: We share our experience of using droplet digital polymerase chain reaction (DdPCR) in liquid biopsy specimens for detecting primary and secondary epidermal growth factor receptor (EGFR) mutations among patients with nonsmall-cell lung can
Externí odkaz:
https://doaj.org/article/ce6daac81a684aa0a9817e9fc4338ed9
Autor:
Moushumi Suryavanshi, Manoj Kumar Panigrahi, Dushyant Kumar, Haristuti Verma, Mumtaz Saifi, Bharti Dabas, Ullas Batra, Dinesh Doval, Anurag Mehta
Publikováno v:
Lung India, Vol 34, Iss 5, Pp 411-414 (2017)
Background: The frequency of ROS1 rearrangement in non-small cell lung cancers has been reported from 1.6% to 2.3%. Materials and Methods: We examined 105 lung adenocarcinoma patients for ROS1 rearrangement which were negative for EGFR and anaplastic
Externí odkaz:
https://doaj.org/article/c4d9d4efb5af4adb810c8eb952e2d262
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 23(7)
An utmost increase of breast cancer burden during the last several decades was reported in Asian countries. Findings from literature confirm that risk factors of breast cancers can be modifiable and non-modifiable in nature.The present study is desig
Publikováno v:
Journal of Clinical Pathology. 74:106-110
AimsThe present study investigated the incidence and spectrum of human epidermal growth factor receptor 2 (HER2) mutations, associated clinicopathological characteristics and the co-occurrence ofHER2gene amplification in theHER2gene mutated cases in
Autor:
Manoj Kumar Panigrahi, Smreti Vasudevan, Ullas Batra, Sanjeev Sharma, Anurag Mehta, Moushumi Suryavanshi, Mumtaz Saifi
Publikováno v:
Applied Cancer Research, Vol 40, Iss 1, Pp 1-12 (2020)
Background Next-generation sequencing (NGS) based assay for finding an actionable driver in non-small-cell lung cancer is a less used modality in clinical practice. With a long list of actionable targets, limited tissue, arduous single-gene assays, t
Publikováno v:
Lung Cancer: Targets and Therapy. 11:19-25
Background The ROS1 gene is a member of the "sevenless" subfamily of tyrosine-kinase insulin-receptor genes. ROS1-fusion rearrangement causes constitutive downstream signal transduction, with an oncogenic role in non-small-cell lung carcinoma (NSCLC)
Autor:
Haristuti Verma, Moushumi Suryavanshi, Mumtaz Saifi, Dushyant Kumar, Sanjeev Sharma, Anurag Mehta, Jiten Jaipuria, Simran Tandon, Bhudev C. Das, Manoj Kumar Panigrahi, Dinesh Chandra Doval
Publikováno v:
South Asian Journal of Cancer
Background: Droplet digital polymerase chain reaction (DDPCR) is a recent modality for detecting Her2 expression which is quantitative, cheaper, easier to standardize, and free from interobserver variation. Purpose: The purpose of this study is to in
Autor:
Irfan Chowdhary, Smreti Vasudevan, Gayatri Viswakarma, Manoj Kumar Panigrahi, Poojan Agarwal, Divya Doval, Nayana N Sriramanakoppa, Dushyant Kumar, Mumtaz Saifi, Anurag Mehta, Moushumi Suryavanshi
Publikováno v:
South Asian Journal of Cancer
Background: Lung cancer is the leading cause of cancer-related mortality worldwide. Genome-directed therapy is less toxic, prolongs survival and provides a better quality of life. Predictive biomarker testing, therefore, has become a standard of care
Autor:
Anurag, Mehta, Shrinidhi, Nathany, Rupal, Tripathi, Sanjeev Kumar, Sharma, Mumtaz, Saifi, Ullas, Batra
Publikováno v:
Journal of clinical pathology. 74(2)
The present study investigated the incidence and spectrum of human epidermal growth factor receptor 2 (HER2) mutations, associated clinicopathological characteristics and the co-occurrence ofAll patients with advanced lung adenocarcinoma (LUAD) who u
Autor:
Dinesh Chandra Doval, Bharti Dabas, Manoj Kumar Panigrahi, Moushumi Suryavanshi, Mumtaz Saifi, Dushyant Kumar, Ullas Batra, Anurag Mehta, Haristuti Verma
Publikováno v:
Lung India, Vol 34, Iss 5, Pp 411-414 (2017)
Lung India : Official Organ of Indian Chest Society
Lung India : Official Organ of Indian Chest Society
Background: The frequency of ROS1 rearrangement in non-small cell lung cancers has been reported from 1.6% to 2.3%. Materials and Methods: We examined 105 lung adenocarcinoma patients for ROS1 rearrangement which were negative for EGFR and anaplastic